The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEND.L Regulatory News (VEND)

  • There is currently no data for VEND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Disposal of All Assets

23 Dec 2021 17:15

RNS Number : 6864W
Ventus VCT plc
23 December 2021
 

23 December 2021

Ventus VCT plc and Ventus 2 VCT plc

(the "Companies")

Completion of Disposal of All Assets

The boards of the Companies are pleased to announce that the sale of the Companies' assets was completed earlier on today[1]. The expected net proceeds to shareholders from the sale, together with the dividends paid to shareholders in August 2021, materially exceed the indicative net proceeds set out in the circular to shareholders of the Companies dated 13 April 2021.

Overview of the Sale Process

At the general meetings held on 19 May 2021, shareholders in both Companies overwhelmingly voted in favour of the resolution proposed to dispose of the Companies' assets and discontinue the Companies as venture capital trusts.

The Companies subsequently appointed Ernst & Young LLP ("EY") to advise the boards on the market value of the assets and to oversee the sale transaction.

The boards, guided by EY, assessed a range of potential transaction paths with reference to a number of key parameters.

After careful evaluation, a joint bid from Temporis Operational Renewable Energy Strategy LP ("TORES") and Temporis Investment Strategy V LP ("TIS V") was determined by the boards as the most attractive to the Companies. The bid was at a materially higher level than the best indicative price previously received and used to calculate the potential net proceeds to shareholders in the circular to shareholders of the Companies dated 13 April 2021. This increase in price was achieved despite subsequent deteriorations in the UK corporation tax rate (payable by the investee companies of the Companies).

Both TORES and TIS V are funds managed by entities related to Temporis Capital Limited, the Companies' investment manager. Therefore, throughout the process, measures were implemented to manage any conflicts appropriately. EY's engagement as a third party adviser was also central to this process.

Expected Net Proceeds from the Sale

The total expected net proceeds to shareholders of the Companies from the sales, including an estimation of all future expenses until final liquidation, are as follows:

Ventus

 

Ordinary Shares

C Shares

D Shares

 

Pence per share

Pence per share

Pence per share

Net proceeds to shareholders

122.9

153.7

201.8

 

 

Ventus 2

 

Ordinary Shares

C Shares

D Shares

 

Pence per share

Pence per share

Pence per share

Net proceeds to shareholders

92.3

155.7

203.9

 No forecast or projection is expressed or implied from the statements above.

Dividend Declaration

The following special interim dividends, which were referred to in the interim financial statements of the Companies released on 29 November 2021, have been declared by the Companies today:

Ventus

 

Ordinary Shares

C Shares

D Shares

 

Pence per share

Pence per share

Pence per share

Special interim dividend declared

37.0

64.0

11.0

 

Ventus 2

 

Ordinary Shares

C Shares

D Shares

 

Pence per share

Pence per share

Pence per share

Special interim dividend declared

47.0

64.0

11.0

 

These dividends will be paid on 21 January 2022 to those Ordinary, C and D shareholders on the register as at the close of business on 7 January 2022. The ex-dividend dates will be 6 January 2022.

Further Distributions

The remainder of the sale proceeds will be distributed by the liquidators, subject to shareholders placing the Companies into a members' voluntary liquidation ("MVL") at general meetings of the Companies which will be convened shortly. The Companies intend to issue a joint circular to convene these general meetings early in the New Year.

It is expected that the liquidators will distribute the majority of the remaining net proceeds very shortly after appointment, although ten percent of the sales proceeds must be retained until the end of February as a condition of the sale. The remaining net proceeds are anticipated to be returned to shareholders of the Companies as soon as possible thereafter.

Market Abuse Regulation

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

[1] The completion of the sale of one asset is contingent on the passing of all the resolutions at general meetings of the Companies which will be convened shortly.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISTJBRTMTBTBTB
Date   Source Headline
2nd Feb 20221:21 pmRNSResult of Meeting
7th Jan 20221:35 pmRNSCircular - proposals for winding up the Company
7th Jan 20221:29 pmRNSCircular - proposals for winding-up the Company
23rd Dec 20215:19 pmRNSCompletion of Disposal of All Assets
23rd Dec 20215:15 pmRNSCompletion of Disposal of All Assets
22nd Jul 20212:20 pmRNSResult of AGM - Shareholder Questions and Answers
22nd Jul 20212:06 pmRNSResult of AGM
21st Jun 202111:10 amRNSAnnual Financial Report
19th May 20216:17 pmRNSResult of General Meeting
7th May 20216:02 pmRNSReplacement: QUESTIONS PURSUANT TO THE CIRCULAR
7th May 20213:35 pmRNSQUESTIONS PURSUANT TO THE CIRCULAR
13th Apr 20215:45 pmRNSIssue of circular replacement
13th Apr 20215:23 pmRNSIssue of circular
1st Mar 20217:00 amRNSProposed Disposal of Assets
11th Nov 20204:16 pmRNSHalf-year Report
20th Aug 20203:05 pmRNSAGM shareholder questions and answers
20th Aug 20203:02 pmRNSResult of AGM
31st Jul 20203:57 pmRNSInvestment Management Agreement update
6th Jul 20209:01 amRNSAnnual Financial Report & Notice of AGM
18th Nov 201910:12 amRNSHalf-year Report
1st Oct 20199:33 amRNSChanges to the Board of Directors
9th Aug 20192:23 pmRNSResult of AGM and poll
8th Aug 201910:17 amRNSAGM presentation
8th Aug 20199:39 amRNSAdditional information disclosures
19th Jul 20198:47 amRNSDirector/PDMR Shareholding
1st Jul 20191:48 pmRNSDirector/PDMR Shareholding
25th Jun 20197:53 amRNSAnnual Financial Report
17th Jun 20195:33 pmRNSDirector Appointment
5th Jun 20194:12 pmRNSRequisition Notice
28th May 20191:08 pmRNSChange of Registrar
5th Feb 201911:20 amRNSInterim Update
30th Oct 20189:45 amRNSHalf-year Report
25th Jul 20189:26 amRNSResult of AGM
31st Oct 20171:31 pmRNSHalf-year Report
1st Nov 201611:26 amRNSStrategy Note
1st Nov 20169:07 amRNSHalf-year Report
1st Sep 20161:50 pmRNSInterim Update
12th Aug 20162:01 pmRNSAGM follow up
22nd Jul 20169:10 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.